Key Takeaway
Tirzepatide insurance coverage guide for 2026. Learn which plans cover Mounjaro and Zepbound, how to get prior authorization, appeal denials, and find affordable alternatives.
Tirzepatide insurance coverage in 2026 varies widely depending on your plan, your diagnosis, and which brand you're prescribed. Some commercial insurance plans cover Mounjaro for type 2 diabetes and Zepbound for weight management, but many still exclude weight loss medications. Our team at FormBlends helps patients manage these challenges every day, and we have put together everything you need to know about coverage, costs, and alternatives.
Overview: the Insurance space for Tirzepatide
Tirzepatide is sold under two brand names, each with different insurance implications:
- Mounjaro: Approved for type 2 diabetes. Insurance coverage is more common for this indication.
- Zepbound: Approved for chronic weight management. Coverage is less consistent since many plans still classify obesity drugs as non-important.
The fundamental challenge is that obesity is still not treated as a disease by many insurance formularies, even though the American Medical Association recognized it as a chronic disease over a decade ago.
Which Insurance Plans Cover Tirzepatide?
Commercial/Employer Plans
Coverage varies significantly by employer. Large employers are increasingly adding GLP-1 coverage, but many mid-size and small employers haven't. As of 2026: For a complete cost breakdown, see our best tirzepatide compounding pharmacies.
View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
- Roughly 40-50% of large employer plans cover at least one GLP-1 for weight management
- Coverage for diabetes indication (Mounjaro) is more common at 70-80% of commercial plans
- Prior authorization is almost always required
Medicare
Medicare Part D has historically excluded coverage for weight loss medications. But legislative efforts have been underway to change this. As of early 2026, Medicare coverage for anti-obesity medications remains limited, though Mounjaro may be covered when prescribed for type 2 diabetes.
Medicaid
Medicaid coverage varies by state. Some state Medicaid programs cover tirzepatide for diabetes, while fewer cover it for obesity alone. Check your state's specific formulary for the most current information.
Tricare
Tricare has been expanding coverage for GLP-1 medications. Tirzepatide for type 2 diabetes is generally covered. Weight management coverage depends on the specific Tricare plan.
Insurance Coverage Comparison
| Plan Type | Mounjaro (Diabetes) | Zepbound (Weight Loss) | Prior Auth Required |
|---|---|---|---|
| Large employer commercial | Often covered | Sometimes covered | Usually yes |
| Small employer commercial | Sometimes covered | Rarely covered | Yes |
| Medicare Part D | Sometimes covered | Rarely covered | Yes |
| Medicaid | Varies by state | Rarely covered | Yes |
| Tricare | Generally covered | Limited | Yes |
| ACA Marketplace | Varies by plan | Rarely covered | Yes |
How Prior Authorization Works
Almost every insurance plan that covers tirzepatide requires prior authorization. Here is what that process looks like:
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →- Your provider submits a request to your insurance company with clinical documentation showing medical necessity.
- Documentation typically includes: your BMI, weight-related comorbidities, previous weight loss attempts, lab results, and your diagnosis code.
- The insurance company reviews the request, usually within 5-15 business days.
- You receive approval or denial. Approval may be for a specific timeframe (often 6-12 months) before re-authorization is needed.
Tips for a Successful Prior Authorization
- Ensure your provider documents your BMI and all weight-related conditions
- Include records of previous weight loss attempts (diets, exercise programs, other medications)
- Provide recent lab work showing metabolic risk factors
- Use the correct diagnosis codes (E66.01 for morbid obesity, E11 for type 2 diabetes)
What to Do If You Are Denied Coverage
Step 1[1]: Understand the Reason
Insurance companies must provide a written explanation for denial. Common reasons include:
- Weight loss medications excluded from your plan's formulary
- Insufficient documentation of medical necessity
- Requirement to try other treatments first (step therapy)
- BMI not meeting the plan's threshold
Step 2: Appeal the Decision
You have the right to appeal. Most plans offer at least two levels of appeal:
- Internal appeal: Your provider writes a letter of medical necessity with additional documentation.
- External appeal: If the internal appeal is denied, you can request an independent review by a third party.
Step 3: Explore Alternatives
If appeals fail, you still have options:
- Compounded tirzepatide through a telehealth provider like FormBlends
- Manufacturer savings programs or coupons
- Patient assistance programs
- Switching to a different GLP-1 that may be covered
Cost Without Insurance
| Option | Monthly Cost | Notes |
|---|---|---|
| Mounjaro (brand) | $900-$1,200+ | Retail pharmacy price |
| Zepbound (brand) | $900-$1,200+ | Retail pharmacy price |
| Compounded tirzepatide | $300-$600 | Through licensed telehealth |
$1,000-$1,200/mo (brand) $1,000-$1,200/mo (brand) From $349 GLP-1 cost without insurance
Manufacturer Savings Programs
Eli Lilly offers savings programs for both Mounjaro and Zepbound:
- Mounjaro Savings Card: Eligible patients with commercial insurance may pay as little as $25 per fill. Check current eligibility requirements as these programs change frequently.
- Zepbound Savings Card: Similar programs exist for Zepbound. Cash-pay patients may also qualify for reduced pricing.
These programs typically exclude government-funded insurance (Medicare, Medicaid, Tricare).
Why Compounded Tirzepatide Is an Alternative
For patients who can't get insurance coverage, compounded tirzepatide through a physician-supervised telehealth program offers a viable path. Compounded medications contain compounded formulations of the active ingredient but are prepared by licensed compounding pharmacies. Benefits include:
- Significantly lower cost than brand-name
- No insurance prior authorization needed
- Available regardless of formulary restrictions
- Bundled with physician supervision and ongoing care
Getting Started Without Insurance Coverage
At FormBlends, we work with patients who don't have insurance coverage for tirzepatide every day. Our program includes:
- Free online medical consultation
- Physician-supervised treatment with personalized dosing
- Compounded tirzepatide at accessible pricing
- Ongoing medical support with dose adjustments and check-ins
Tirzepatide online prescription
Frequently Asked Questions
Does insurance cover tirzepatide for weight loss?
Some commercial insurance plans cover Zepbound for weight management, but many still exclude anti-obesity medications. Coverage is more common for Mounjaro when prescribed for type 2 diabetes. Check your specific plan's formulary or call your insurance company directly.
How much does tirzepatide cost with insurance?
With insurance coverage, out-of-pocket costs typically range from $25 to $150 per month, depending on your plan's copay or coinsurance structure. Manufacturer savings cards can reduce this further.
Can I use a savings card with insurance?
Yes, if you have commercial insurance. Manufacturer savings cards can't be combined with government insurance programs like Medicare or Medicaid.
What diagnosis codes help with insurance approval?
Common diagnosis codes include E66.01 (morbid obesity due to excess calories), E66.09 (other obesity due to excess calories), and E11.xx codes for type 2 diabetes. Your provider should use the codes most appropriate for your medical situation.
Is compounded tirzepatide covered by insurance?
Generally no. Compounded medications are typically not covered by insurance. But their lower price point often makes them more affordable than brand-name medications even with insurance copays.
Will Medicare start covering weight loss medications?
There's active legislative effort to expand Medicare coverage for anti-obesity medications. The Treat and Reduce Obesity Act and similar bills have been introduced in Congress. As of early 2026, coverage remains limited but the situation is evolving.
Can I switch from brand-name to compounded to save money?
Yes. Many patients who start on brand-name tirzepatide switch to compounded versions for cost savings. Your provider can help manage the transition to ensure consistent dosing and results.
Medical References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]
- Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. [PubMed | ClinicalTrials.gov | DOI]
- Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3). JAMA. 2021;325(14):1403-1413. [PubMed | ClinicalTrials.gov | DOI]
Do Not Let Insurance Stop You
Insurance coverage for tirzepatide is improving, but it's still inconsistent. The good news is that you have options regardless of your insurance situation. Whether through appeals, savings programs, or affordable compounded alternatives through FormBlends, effective weight loss treatment is within reach. Our team can help you figure out the best path forward. get started with FormBlends